These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 15596707

  • 21. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 22. Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.
    Afify ZAM, Taj MM, Orjuela-Grimm M, Srivatsa K, Miller TP, Edington HJ, Dalal M, Robles J, Ford JB, Ehrhardt MJ, Ureda TJ, Rubinstein JD, McCormack S, Rivers JM, Chisholm KM, Kavanaugh MK, Bukowinski AJ, Friehling ED, Ford MC, Reddy SN, Marks LJ, Smith CM, Mason CC.
    Cancer; 2023 Mar 01; 129(5):780-789. PubMed ID: 36571557
    [Abstract] [Full Text] [Related]

  • 23. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 01; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 24. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E, Özdemir BH, Deniz EE, Tunca MZ, Haberal M.
    Exp Clin Transplant; 2014 Mar 01; 12 Suppl 1():142-8. PubMed ID: 24635813
    [Abstract] [Full Text] [Related]

  • 25. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
    Lones MA, Shintaku IP, Weiss LM, Thung SN, Nichols WS, Geller SA.
    Hum Pathol; 1997 May 01; 28(5):533-9. PubMed ID: 9158700
    [Abstract] [Full Text] [Related]

  • 26. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B, Yousem SA.
    Arch Pathol Lab Med; 1995 May 01; 119(5):418-23. PubMed ID: 7748068
    [Abstract] [Full Text] [Related]

  • 27. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S, Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Clin Infect Dis; 2013 Sep 01; 57(6):794-802. PubMed ID: 23771985
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A, Kohno A, Fukuyama R, Elsayed AA, Nakamura S.
    Hum Pathol; 2017 Jan 01; 59():147-151. PubMed ID: 27569297
    [Abstract] [Full Text] [Related]

  • 29. A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.
    Kinch A, Baecklund E, Backlin C, Ekman T, Molin D, Tufveson G, Fernberg P, Sundström C, Pauksens K, Enblad G.
    Acta Oncol; 2014 May 01; 53(5):669-79. PubMed ID: 24164103
    [Abstract] [Full Text] [Related]

  • 30. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 01; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 31. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, Issa N.
    Clin Transplant; 2016 Jan 01; 30(1):60-5. PubMed ID: 26497471
    [Abstract] [Full Text] [Related]

  • 32. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM.
    Chest; 2003 Oct 01; 124(4):1242-9. PubMed ID: 14555552
    [Abstract] [Full Text] [Related]

  • 33. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V, Sutton L, Dorent R, Davi F, Bitker MO, Gabarre J, Charlotte F, Ghoussoub JJ, Fourcade C, Fischer A.
    J Clin Oncol; 1995 Apr 01; 13(4):961-8. PubMed ID: 7707124
    [Abstract] [Full Text] [Related]

  • 34. Posttransplant lymphoproliferative disorders in lung transplant recipients: clinical experience at a single center.
    Angel LF, Cai TH, Sako EY, Levine SM.
    Ann Transplant; 2000 Apr 01; 5(3):26-30. PubMed ID: 11147026
    [Abstract] [Full Text] [Related]

  • 35. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct 01; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 36. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan 01; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 37. Posttransplant lymphoproliferative disorders in renal allograft recipients: report of 53 cases of a French multicenter study. PTLD French Working Group.
    Caillard S, Lachat V, Moulin B.
    Transpl Int; 2000 Jan 01; 13 Suppl 1():S388-93. PubMed ID: 11112039
    [Abstract] [Full Text] [Related]

  • 38. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 39. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
    Ziarkiewicz-Wróblewska B, Górnicka B, Suleiman W, Ołdakowska-Jedynak U, Wróblewski T, Bogdańska M, Ziółkowski J, Nowacka-Cieciura E, Foroncewicz B, Pileri SA, Durlik M, Paczek L, Krawczyk M, Wasiutyński A.
    Transplant Proc; 2006 Oct 15; 38(1):168-72. PubMed ID: 16504694
    [Abstract] [Full Text] [Related]

  • 40. Epstein-Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant.
    Dotti G, Fiocchi R, Motta T, Gamba A, Gotti E, Gridelli B, Borleri G, Manzoni C, Viero P, Remuzzi G, Barbui T, Rambaldi A.
    Transplantation; 2000 Mar 15; 69(5):827-33. PubMed ID: 10755535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.